2021-04-12 · BIOLASE, Inc. has a market cap of $152.4 Million and is expected to release its quarterly earnings report on March 25, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the BIOL stock to lose ahead of the earnings release.

Aktieinformation BIOLASE Inc. Utdelning BIOLASE Inc · Resultat BIOLASE Inc · Diagram BIOLASE Inc · Dividend BIOLASE Inc · Resultaten BIOLASE Inc

Patent number: 10877630. Abstract: Embodiments of the invention provide a system of controlling a dental laser system. The system can include a dental laser and a control system for controlling certain functions of the dental laser. 2021-03-14 · Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market. BIOL.

Biolase patent 2021

IRVINE, Calif., U.S.: The dental laser innovator BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the U.S. with more than 330 affiliated practices in 20 states. 2021-01-26 · FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is 2021-04-15 · BIOLASE Inc. [NASDAQ: BIOL] loss -3.07% on the last trading session, reaching $0.85 price per share at the time. The company report on March 30, 2021 that BIOLASE Announces Collaboration with Einstein Healthcare Network’s Residency in Endodontics. 2021-01-12 · Biolase Announces Agreement with DSO Dental Care Alliance Posted on January 12, 2021.

2021-02-05 · BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.

The company report on March 30, 2021 that BIOLASE Announces Collaboration with Einstein Healthcare Network’s Residency in Endodontics. 2021-01-12 · Biolase Announces Agreement with DSO Dental Care Alliance Posted on January 12, 2021.

16 Mar 2021 FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire via and 40 patent- pending technologies designed to provide biologically and

09 May 2012. The company has filed suit against a European competitor, and is also the subject of legal action from CAO Group. Two recently filed patent disputes involving Biolase indicate that the California-based developer of dental laser systems has yet to find itself sailing in calm legal waters. BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance Wednesday, 3 March 2021 2020-09-24 · BIOLASE Inc. [BIOL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.00.
Tolk utbildning örebro

2021-02-01 · The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021. FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned special meeting of stockholders initially held on January 22, 2021 (the "Special Meeting"), which will reconvene on Tuesday Biolase market cap history and chart from 2006 to 2020.

Justia - Patents - Patents and Patent Application Resources Patents Assigned to BIOLASE, Inc. Publication date: March 18, 2021 Applicant: Biolase, Inc. BIOLASE, Inc. (BIOL) was awarded a new patent titled "Non-Contact Handpiece for Laser Tissue Cutting" by the U.S. Patent and Trademark Office. IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE 271 patented and 40 patent-pending technologies designed to provide biologically BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics. Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications. Biolase laser products are proprietary and are protected by about 271 patents and 40 patent-pending technologies.
Certifikát italský jazyk

natur samhälle program
vad är en oktroj
analytisk statistik
rabatt på restaurang stockholm
leos lekland kristianstad
beskattning allemansfonder
otålig mot

March 30, 2021 BIOLASE notes the goal of the program is to offer residents hands-on experience with dental lasers that are already in use

co.

2021-01-05 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and January 15, 2021 | Events, Interviews, News. IRVINE, Calif., U.S.: The dental laser innovator BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the U.S. with more than 330 affiliated practices in 20 states.

Two recently filed patent disputes involving Biolase indicate that the California-based developer of dental laser systems has yet to find itself sailing in calm legal waters. BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance Wednesday, 3 March 2021 2020-09-24 · BIOLASE Inc. [BIOL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.00. With this latest performance, BIOL shares dropped by -13.70% in over the last four-week period, additionally sinking by -49.14% over the last 6 months – not to mention a drop of -71.80% in the past year of trading. Dental laser manufacturer Biolase Inc. has received a US patent for a noncontact handpiece that cuts both hard and soft tissue using the company&rsquo BIOLASE Inc (BIOLASE Inc ()) has risen Tuesday morning, with the stock increasing 6.62% in pre-market trading to 1.45.BIOL's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals.